Two cases of acute dexmedetomidine withdrawal syndrome following prolonged infusion in the intensive care unit: Report of cases and review of the literature

Human and Experimental Toxicology

Volumn 32, Issue 1, 2013, Pages 107-110

  Kukoyi, A T ^a   Coker, S A ^b   Lewis, L D ^b   Nierenberg, D W ^b  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

Clinical toxicology; pharmacodynamics; receptors

Indexed keywords

CISPLATIN; CLONIDINE; DEXMEDETOMIDINE; IFOSFAMIDE; METOPROLOL; PACLITAXEL;

ADULT; AGITATION; CASE REPORT; CERVICAL GRANULOCYTIC SARCOMA; DRUG DOSE TITRATION; DRUG WITHDRAWAL; EXTUBATION; FEMALE; GRANULOCYTIC SARCOMA; HUMAN; HYPERTENSION; MEDICAL HISTORY; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; REVIEW; TACHYCARDIA; WITHDRAWAL SYNDROME;

CLONIDINE; DEXMEDETOMIDINE; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; INFUSIONS, INTRAVENOUS; INTENSIVE CARE UNITS; MIDDLE AGED; SUBSTANCE WITHDRAWAL SYNDROME; SYMPATHOLYTICS;

EID: 84871532984     PISSN: 09603271     EISSN: 14770903     Source Type: Journal    
DOI: 10.1177/0960327112454896     Document Type: Review

References (11)

1. Mantz J. Alpha2-adrenoceptor agonists: analgesia, sedation, anxiolysis, haemodynamics, respiratory function and weaning. Best Pract Res Clin Anaesthesiol. 2000 ; 14: 433-448
2. Virtanen R, Savola JM, Saano V, Nyman L. Characterization of the selectivity, specificity and potency of medetomidine as an alpha 2-adrenoceptor agonist. Eur J Pharmacol. 1988 ; 150: 9-14
3. Venn M, Newman J, Grounds M. A phase II study to evaluate the efficacy of dexmedetomidine for sedation in the medical intensive care unit. Intensive Care Med. 2003 ; 29: 201-207
4. Precedex (dexmedetomidine hydrochloride) prescribing information, http://www.precedex.com/wp-content/uploads/2010/02/Precedex-Full-PI.pdf(2010, accessed 18 November 2011).
5. Enomoto Y, Kudo T, Saito T, Hori T, Kaneko M, Matsui A, et al. Prolonged use of dexmedetomidine in an infant with respiratory failure following living donor liver transplantation. Paediatr Anaesth. 2006 ; 16: 1285-1288
6. Darnell C, Steiner J, Szmuk P, Sheeran P. Withdrawal from multiple sedative agent therapy in an infant: is dexmedetomidine the cause or the cure?. Pediatr Crit Care Med. 2010 ; 11: e1 - e3
7. Weber MD, Thammasitboon S, Rosen DA. Acute discontinuation syndrome from dexmedetomidine after protracted use in a pediatric patient. Paediatr Anaesth. 2008 ; 18: 87-88
8. Tobias JD. Dexmedetomidine: are tolerance and withdrawal going to be an issue with long-term infusions?. Pediatr Crit Care Med. 2010 ; 11: 158-160
9. Brodsky JB, Bravo JJ. Acute postoperative clonidine withdrawal syndrome. Anesthesiol. 1976 ; 44: 519-520
10. Miller JL, Allen C, Johnson PN. Neurologic withdrawal symptoms following abrupt discontinuation of a prolonged dexmedetomidine infusion in a child. J Pediatr Pharmacol Therapeut. 2010 ; 15: 38
11. Catapress (clonidine hydrochloride, USP) prescribing information, http://bidocs.boehringer-ingelheim.com/BIWebAccess/ViewServlet.ser?docBase= renetnt&folderPath=/Prescribing+Information/PIs/Catapres+Tabs/CatapresTabs. pdf(2010, accessed 13 February 2012).